Patel Tushar Bhikhubhai — SEC Form 4 filings
SEC reporting owner CIK 1745375. 2 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2025-03-17 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,000,000 shares, $41,750,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: sale of 5,000,000 shares @ $8.35 ($41,750,000) in Amneal Pharmaceuticals, Inc., filed 2025-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | 10% owner | 2 | — | 1 leg · 5,000,000 sh · $41,750,000 | 1 |
Form 4 filings — Patel Tushar Bhikhubhai
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 12,763,469 | EDGAR |
| 2025-03-17 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 5,000,000 @ $8.35 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1745375 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →